Peripheral T/NK Cell Lymphoma (R/R PTCL)
1 clinical trials · Condition
◉ Watch Peripheral T/NK Cell Lymphoma (R/R PTCL)
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma (NCT05274997) | Shanghai YingLi Pharmaceutical Co. Ltd. | 2022-05-01 |
Track Peripheral T/NK Cell Lymphoma (R/R PTCL) automatically
Every clearance here is in the API, with alerts when new ones post.